Recombinant SARS-CoV-2 Spike (Sotrovimab Biosimilar) antibody

Catalog No. ABIN7488266

The Mammalian Cells Monoclonal anti-SARS-CoV-2 Spike (Sotrovimab Biosimilar) antibody (ABIN7488266) specifically detects SARS-CoV-2 Spike (Sotrovimab Biosimilar) in ELISA and WB. The antibody is reactive with Human samples.

Quick Overview for Recombinant SARS-CoV-2 Spike (Sotrovimab Biosimilar) antibody (ABIN7488266)

Target: SARS-CoV-2 Spike (Sotrovimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Conjugate: This SARS-CoV-2 Spike (Sotrovimab Biosimilar) antibody is un-conjugated

Application: ELISA, Western Blotting (WB)

Grade: Research Grade

Product Details anti-SARS-CoV-2 Spike (Sotrovimab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Sotrovimab Biosimilar - Anti-Spike glycoprotein mAb

Characteristics: Antibody Type: Human IgG

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS buffer pH 7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for SARS-CoV-2 Spike (Sotrovimab Biosimilar)

Target: SARS-CoV-2 Spike (Sotrovimab Biosimilar)

Target Type: Biosimilar